Кореспондиращ автор: Б. Добрева-Яцева ( bistra0806@yahoo.com ) Академик редактор: Николай Рунев © Б. Добрева-Яцева, Ф. Николов, Р. Райчева, М. Токмакова. Това е статия отворен достъп разпространява под условията на Creative Commons Attribution License (CC BY 4.0), която позволява използване без ограничения, разпространение, и възпроизвеждане на всякакъв носител, при условие на оригиналния автор и източник са кредитирани. Цитат:
Добрева-Яцева Б, Николов Ф, Райчева Р, Токмакова М (2022) Инфекциозен ендокардит – съвременен профил. Българска Кардиология 28(4): 92-111. https://doi.org/10.3897/bgcardio.28.e90366 |
Corresponding author: B. Dobreva-Yatseva ( bistra0806@yahoo.com ) Academic editor: Nikolay Runev © B. Dobreva-Yatseva, F. Nikolov, R. Raycheva, M. Tokmakova. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Citation:
Dobreva-Yatseva B, Nikolov F, Raycheva R, Tokmakova M (2022) Infectious endocarditis – current profile. Bulgarian Cardiology 28(4): 92-111. https://doi.org/10.3897/bgcardio.28.e90366 |
Infective endocarditis (IE) is a disease of the endocardium of the heart and the endocardium of the great vessels, with infection affecting heart valves (native or prosthetic) and subvalvular structures and, in the last few decades, indwelling intracardiac devices or catheters. It is a life-threatening disease with a wide distribution worldwide. IE was first described 350 years ago, but it continues to be a huge challenge for doctors for several reasons. First – IE is a changing disease. Nowadays, the profile of patients with IE has significantly changed in terms of age, predisposing factors, microbiological causative agent, clinical picture, complications, therapeutic approach. Second, despite modern imaging and microbiological methods, diagnostics often encounter serious difficulties and delays. Third, the improvement in medical and surgical treatment in recent decades has not changed the rates of mortality and severe complications. Knowing the current profile of patients with IE helps in timely and accurate diagnosis, which is key to starting adequate treatment. Early identification of high-risk patients is important for the therapeutic approach, especially when deciding on operative treatment. This is associated with a reduction in in-hospital mortality and an improvement in the long-term prognosis of patients.